Cytokines, viruses, and graft-versus-host disease

被引:44
作者
Holler, E [1 ]
机构
[1] Univ Regensburg, Hosp Franz Josef Strauss, Dept Hematol Oncol, D-93042 Regensburg, Germany
关键词
D O I
10.1097/00062752-200211000-00002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Proinflarnmatory cytokines released by host tissues during conditioning treatment and interferon gamma released from donor T cells play a major role in acute graft-versus-host disease (GVHD). In the past year the interaction of cytokines has been elucidated further. Host antigen-presenting cells play a key role in the induction of allogeneic recognition. Their activity is modulated by cytokines such as flt3-ligand, viruses, and donor T cells. Expansion of donor T cells is crucial for the pathogenesis of acute GVHD. Cytokines of the T helper 1 response-IFN-gamma, IL-12, and IL-18-regulate the expansion of donor and host cells via the induction of Fas and FasL and subsequent apoptosis. However TNF-alpha, FasL, and IL-1 also cause damage to target cells. Cytokine and receptor gene polymorphism has an impact on the activity of both host and donor cell activation. Genetic factors, conditioning treatment, lipopolysaccharides (LPS) from gram-negative microorganisms, viral infections, and donor T cells determine the activity level of host antigen-presenting cells and macrophages, which have an impact on acute GVHD and other complications of allogeneic stem cell transplantation. (C) 2002 Lippincott Williams Wilkins, Inc.
引用
收藏
页码:479 / 484
页数:6
相关论文
共 58 条
[1]   A role for transforming growth factor-β1 in the increased pneumonitis in murine allogeneic bone marrow transplant recipients with graft-versus-host disease after pulmonary herpes simplex virus type 1 infection [J].
Adler, H ;
Beland, JL ;
Kozlow, W ;
Del-Pan, NC ;
Kobzik, L ;
Rimm, IJ .
BLOOD, 1998, 92 (07) :2581-2589
[2]   Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease [J].
Alpdogan, O ;
Schmaltz, C ;
Muriglan, SJ ;
Kappel, BJ ;
Perales, MA ;
Rotolo, JA ;
Halm, JA ;
Rich, BE ;
van den Brink, MRM .
BLOOD, 2001, 98 (07) :2256-2265
[3]   A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation [J].
Antin, JH ;
Lee, SJ ;
Neuberg, D ;
Alyea, E ;
Soiffer, RJ ;
Sonis, S ;
Ferrara, JLM .
BONE MARROW TRANSPLANTATION, 2002, 29 (05) :373-377
[4]   Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants [J].
Aubert, G ;
Hassan-Walker, AF ;
Madrigal, JA ;
Emery, VC ;
Morte, C ;
Grace, S ;
Koh, MBC ;
Potter, M ;
Prentice, HG ;
Dodi, IA ;
Travers, PJ .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (08) :955-963
[5]   Expansion of cytolytic CD8+ natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon γ production [J].
Baker, J ;
Verneris, MR ;
Ito, M ;
Shizuru, JA ;
Negrin, RS .
BLOOD, 2001, 97 (10) :2923-2931
[6]   Flt3 ligand (FL) treatment of murine donors does not modify graft-versus host disease (GVHD) but FL treatment of recipients post-bone marrow transplantation accelerates GVHD lethality [J].
Blazar, BR ;
McKenna, HJ ;
Panoskaltsis-Mortari, A ;
Taylor, PA .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2001, 7 (04) :197-207
[7]  
Bordigoni Pierre, 2001, Clinical Infectious Diseases, V32, P1290, DOI 10.1086/319984
[8]   TNF-TNFR2 interactions are critical for the development of intestinal graft-versus-host disease in MHC class II-disparate (C57BL/6J→C57BL/6J x bm12)F1 mice [J].
Brown, GR ;
Lee, E ;
Thiele, DL .
JOURNAL OF IMMUNOLOGY, 2002, 168 (06) :3065-3071
[9]   Interferon-γ and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation [J].
Cavet, J ;
Dickinson, AM ;
Norden, J ;
Taylor, PRA ;
Jackson, GH ;
Middleton, PG .
BLOOD, 2001, 98 (05) :1594-1600
[10]   Relationship between HLA alleles and cytomegalovirus infection after allogeneic hematopoietic stem cell transplant [J].
Chen, Y ;
Rocha, V ;
Bittencourt, H ;
Scieux, C ;
Loiseau, P ;
Espérou, H ;
Devergie, A ;
Guardiola, P ;
Soclé, G ;
Chevret, S ;
Charron, D ;
Gluckman, E ;
Ribaud, P .
BLOOD, 2001, 98 (02) :500-501